Home > Cardiology > AHA 2020 > Atrial Fibrillation > AF screening in older adults at primary care visits

AF screening in older adults at primary care visits

Presented By
Dr Steven Lubitz, Massachusetts General Hospital, USA
Conference
AHA 2020
Trial
VITAL-AF

In the cluster randomised VITAL-AF trial, screening patients during primary care visits using a single-lead ECG was feasible but not associated with a significant increase in new atrial fibrillation (AF) diagnoses compared with usual care [1]. However, it may be useful in patients aged 85 years.

Dr Steven Lubitz (Massachusetts General Hospital, USA) said screening in primary care might be optimal because it can identify people who might benefit from treatment at a large scale and enable efficient treatment initiation. In VITAL-AF (NCT03515057), patients aged ≥65 years from 16 hospital- and community-based practices were randomised 1:1 to usual care or AF screening, using an AliveCor single-lead ECG, during routine visits. The primary endpoint was the rate of newly diagnosed AF over a period of 12 months. A total of 30,722 patients...



Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on